Literature DB >> 35750454

Lung Cancer in Serbia.

Milena Cavic1, Tomi Kovacevic2, Bojan Zaric2, Dejan Stojiljkovic3, Natasa Jovanovic Korda4, Milan Rancic5, Radmila Jankovic6, Davorin Radosavljevic7, Goran Stojanovic8, Jelena Spasic7.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35750454     DOI： 10.1016/j.jtho.2022.04.010

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   20.121


× No keyword cloud information.
  4 in total

1.  Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer.

Authors:  Jelena Spasic; Milena Cavic; Nemanja Stanic; Bojan Zaric; Tomi Kovacevic; Davorin Radosavljevic; Ljudmila Nagorni-Obradovic
Journal:  Dose Response       Date:  2022-06-28       Impact factor: 2.623

2.  Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma.

Authors:  Vera Jokic; Katarina Savic-Vujovic; Jelena Spasic; Zoran Bukumiric; Mladen Marinkovic; Davorin Radosavljevic; Milena Cavic
Journal:  Dose Response       Date:  2022-08-04       Impact factor: 2.623

3.  The Presence of EGFR T790M in TKI-Naïve Lung Cancer Samples of Patients Who Developed a T790M-Positive Relapse on First or Second Generation TKI Is Rare.

Authors:  Weiting Li; Klaas Kok; Geok Wee Tan; Pei Meng; Mirjam Mastik; Naomi Rifaela; Frank Scherpen; T Jeroen N Hiltermann; Harry J M Groen; Anthonie J van der Wekken; Anke van den Berg
Journal:  Cancers (Basel)       Date:  2022-07-19       Impact factor: 6.575

4.  Ablating lung cancer, knowing the tumor better.

Authors:  Rafael Rosell; María González-Cao
Journal:  Lancet Reg Health Eur       Date:  2022-08-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.